Phase 3 Alogliptin Pediatric Study
Public ClinicalTrials.gov record NCT02856113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared With Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the efficacy of alogliptin 25 milligram (mg) once daily compared to placebo when administered as monotherapy, or when added onto a background of metformin alone, insulin alone, or a combination of metformin and insulin, as measured by the glycosylated hemoglobin (HbA1c) change from Baseline at Week 26 in pediatric participants with type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT02856113
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 152 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 13, 2016
- Primary completion
- Aug 5, 2021
- Completion
- Feb 13, 2022
- Last update posted
- Oct 18, 2022
2016 – 2022
United States locations
- U.S. sites
- 34
- U.S. states
- 24
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital Research Institute | Little Rock | Arkansas | 72202 | — |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Sherif Khamis | Palmdale | California | 93550 | — |
| Lucile Packard Children's Hospital at Stanford University | Palo Alto | California | 94304 | — |
| Touro University California | Vallejo | California | 94592 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06511 | — |
| Children's National Health System | Washington D.C. | District of Columbia | 20010 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Nemours Childrens Specialty Care - Jacksonville | Jacksonville | Florida | 32207 | — |
| Baptist Diabetes Associates Research | Miami | Florida | 33156 | — |
| University of South Florida/USF Health | Tampa | Florida | 33612 | — |
| Endocrine Consultants Research | Columbus | Georgia | 31904 | — |
| Endocrine Consultants Research - Oak Hill Court | Newnan | Georgia | 30265 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kentucky Health Care | Lexington | Kentucky | 40504 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
| Ochsner Baptist Medical Center | New Orleans | Louisiana | 70115 | — |
| University of Minnesota Masonic Children's Hospital - Pediatric Specialty Care Discovery Clinic | Minneapolis | Minnesota | 55454 | — |
| Gulfside Clinical Research | Gulfport | Mississippi | 39501 | — |
| Saint Louis University | St Louis | Missouri | 63104 | — |
| Horizon View Medical Center | Las Vegas | Nevada | 89149 | — |
| Saint Joseph's Regional Medical Center - Paterson | Paterson | New Jersey | 07503 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Greenville Health System - Patewood | Greenville | South Carolina | 29615 | — |
| Monument Health Clinical Research | Rapid City | South Dakota | 57701 | — |
| UT Le Bonheur Pediatric Specialists | Memphis | Tennessee | 38105 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | — |
| Baylor College of Medicine Advanced Liver Therapies | Houston | Texas | 77030 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
| Seattle Children's Hospital | Seattle | Washington | 98003 | — |
| Multicare Health System Institute for Research and Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
Recently updated Diabetes Mellitus, Type 2 trials
Other public records listing Diabetes Mellitus, Type 2. Sorted by last update posted; newest first. Not a recommendation.
- NCT06920355: Community Pharmacy Produce Prescriptions Active, not recruiting
- NCT07784270: A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight Not yet recruiting
- NCT07783802: A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event Not yet recruiting
- NCT07684144: Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION) Recruiting
- NCT07590193: A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus Recruiting
- NCT07242469: A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02856113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2022 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02856113 live on ClinicalTrials.gov.